- Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
-
Cheung KS, Mok CH, Seto WK, Yuen MF
- KMID: 2538218
- Clin Mol Hepatol.
- 2023 Jan;29(1):176-178.
- doi: 10.3350/cmh.2022.0377
-
- CITED
-
- Close
- SHARE
-
- Close
- Chemopreventive Effect of Metformin on Gastric Cancer Development
-
Cheung KS, Chung KL, Leung WK
- KMID: 2526989
- Gut Liver.
- 2022 Mar;16(2):147-156.
- doi: 10.5009/gnl210132
Although Helicobacter pylori infection is the most important causative factor for gastric cancer (GC), H. pylori eradication alone does not completely eliminate the GC risk. In addition to H. pylori... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
-
Hui KY, Fung J, Cheung KS, Mak LY, Seto WK, Yuen MF
- KMID: 2540416
- Gut Liver.
- 2023 Mar;17(2):280-287.
- doi: 10.5009/gnl220122
Background/Aims: Hepatitis B surface antigen (HBsAg) seroclearance remains uncommon in chronic hepatitis B (CHB) infection. During acute flares of CHB (AFOCHB), alanine aminotransferase elevation reflects a mounting immune response toward... -
- CITED
-
- Close
- SHARE
-
- Close
- Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
-
Lam YF, Seto WK, Tong T, Cheung KS, Lo O, Hung IF, Law WL, Leung WK
- KMID: 2434164
- Intest Res.
- 2018 Oct;16(4):619-627.
- doi: 10.5217/ir.2018.00013
BACKGROUND/AIMS: We determined the rates of metachronous colorectal neoplasm in colorectal cancer (CRC) patients after resection for right (R)-sided or left (L)-sided cancer. METHODS: Consecutive CRC patients who had undergone surgical... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
-
Cheung KS, Mok CH, Mao X, Zhang R, Hung IF, Seto WK, Yuen MF
- KMID: 2534353
- Clin Mol Hepatol.
- 2022 Oct;28(4):890-911.
- doi: 10.3350/cmh.2022.0087
Background/Aims: Data of coronavirus disease 2019 (COVID-19) vaccine immunogenicity among chronic liver disease (CLD) and liver transplant (LT) patients are conflicting. We performed meta-analysis to examine vaccine immunogenicity regarding etiology,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
-
Cheung KS, Lam LK, Hui RWH, Mao X, Zhang RR, Chan KH, Hung IF, Seto WK, Yuen MF
- KMID: 2531378
- Clin Mol Hepatol.
- 2022 Jul;28(3):553-564.
- doi: 10.3350/cmh.2022.0082
Background/Aims: Studies of hepatic steatosis (HS) effect on COVID-19 vaccine immunogenicity are lacking. We aimed to compare immunogenicity of BNT162b2 and CoronaVac among moderate/severe HS and control subjects. Methods: Two hundred... -
- CITED
-
- Close
- SHARE
-
- Close
